Loading...
Images of Yaping Shou
(0 from 0 )1
0
0
News
CHI’s 5th Biomarker World Congress: Signature Event with Cutting-Edge...
www.b3cnewswire.com
Needham, MA, March 26, b3c newswire / - Cambridge Healthtech Institute’s Fifth Annual Biomarker World Congress will be held May , at the Loews...
Trillium Starts Phase 1 Trial of TTI-622 for Treating Myeloma,...
myelomaresearchnews.com
Trillium The…utics recently dosed the first patient in its Phase 1 trial of TTI-622, being developed for the treatment of relapsed or refractory lymphoma...
Telephone & Addresses
WhitePages: Yaping Shou in MA | WhitePages
View Yaping Shou's phone number, address and more on WhitePages. Find 1 listing for Yaping Shou in MA. WhitePages is the largest and most trusted directory, and has
WhitePages: Yaping Xue | Whitepages - Find People, …
Yaping Shou. Age: Unknown; Current: Boxborough, MA; Prior: No known previous cities; Knows: No known associations; View Full Profile View More Details. Yaping Shih ...
Yaping Shou - Everyone411
www.everyone411.com
View more details for Yaping Shou with phone number in Massachusetts. Reliable and accurate information, fast and easy on Everyone411.
Physicians & MDs
The Lancet Haematology, November 2021, Volume 8, Issue
www.thelancet.com
Yaping Shou, Oleg E Akilov; Full-Text HTML; PDF e818. e818. Venetoclax with dose-adjusted EPOCH-R as initial therapy for patients with aggressive B-cell lymphoma: a single-arm, multicentre, phase 1 study. Sarah C Rutherford, Jeremy S Abramson, Nancy L Bartlett, Stefan K Barta, Nadia Khan,
Network Profiles
Interests
Yaping Shou - Patents
www.freshpatents.com
Yaping Shou patents Recent bibliographic sampling of Yaping Shou patents listed/published in the public domain by the USPTO (USPTO Patent Application #,Title):
Business Profiles
patentbuddy: Yaping Shou
GLAXO GROUP LIMITED, Research Triangle Park, NC, US
Books & Literature
Hemostasis and Thrombosis Protocols - Google Books
books.google.de
In Hemostasis and Thrombosis Protocols, leading experimentalists describe in detail their proven, cutting-edge methods for research on hemostasis and...
Transcriptional Regulation of Tissue-specific Expression of the...
books.google.de
Yaping Shou. Allegheny University of the Health Sciences, MCP Hahnemann School of Medicine, [Department of Neoplastic Diseases, Molecular & Cell Biology ...
Related Documents
BIBLIOGRAPHY
www.slideshare.net
... Taimei Yang, Mirjam T Epping, Yaping Shou, Era Pogosova- Agadjanyan, Paula Ladne, Derek L Stirewalt, Janis L Abkowitz, Jerald P Radich ...
Initial Molecular Response at 3 Months May Predict Both Response and...
hwmaint.jco.ascopubs.org
Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop M. Kantarjian, Giovanni Martinelli, Jerald ...
Global Engage 5th China & 3rd Asia Final 15 January
www.conferensum.com
Yaping Shou, Medical Director, Clinical Research,. Millennium: The Takeda Oncology Company. Panel Discussion: Future of Clinical Trials and. Outsourcing to ...
Scientific Publications
A phase I, multicenter, open-label, first-in-human, dose ...
pubmed.ncbi.nlm.nih.gov
Jordi Rodon 1 , Hussein A Tawbi, Anne L Thomas, Ronald G Stoller, Christian P Turtschi, Jose Baselga, John Sarantopoulos, Devalingam Mahalingam, Yaping Shou, Melissa A Moles, Lin Yang, Camille Granvil, Eunju Hurh, Kristine L Rose, Dereck D Amakye, Reinhard Dummer, Alain C Mita
Rapid initial decline in BCR-ABL1 is associated with superior...
bmccancer.biomedcentral.com
We evaluated BCR-ABL1 kinetics in patients treated with nilotinib and analyzed whether a dynamic model of changes in BCR-ABL1 levels over time could be used to...
Publications
Initial molecular response at 3 months may predict both response and...
core.ac.uk
By Susan Branford, Dong-Wook Kim, Simona Soverini, Ariful Haque, Yaping Shou, Richard C. Woodman, Hagop M. Kantarjian, Giovanni Martinelli, Jerald P.
Cancers | Free Full-Text | Clinical Response to Anti-CD
www.mdpi.com
· Jiang, Tony T., Oleg Kruglov, Gloria H.Y. Lin, Angela Minic, Kimberly Jordan, Robert A. Uger, Mark Wong, Yaping Shou, and Oleg E. Akilov "Clinical Response to Anti-CD47 Immunotherapy Is Associated with Rapid Reduction of Exhausted Bystander CD4 + BTLA + T Cells in Tumor Microenvironment of Mycosis Fungoides" Cancers 13, no. 23:
Molecular Biology Studies with Primary Megakaryocytes | SpringerLink
link.springer.com
Megakaryocytes are rare hematopoietic cells comprising only about 0.02–0.05% of the bone marrow nucleated cell population. Because of the relative infrequency...
Reports & Statements
Phase 1 study of mTORC1/2 inhibitor sapanisertib (TAK
www.nature.com
· Aaron Enke, Yaping Shou, Farhad Sedarati & Douglas V. Faller Sarah Cannon Research Institute/Tennessee Oncology, Drug Development Unit, th Ave., North Nashville, TNUSA Howard A ...
Nilotinib is active in chronic and accelerated phase chronic myeloid...
www.nature.com
Original Article
Miscellaneous
Yaping Shou - Venture Partner - Lilly Asia Ventures 礼来亚洲基金 ...
www.linkedin.com
Liked by Yaping Shou This is a dual stain with CD19 (Brown 🟤) and CD8 (Teal🔵) At NovoVita we specialize in Neuroscience, Oncology and disease histopath support If you…
Yaping Shou | Berufsprofil
www.linkedin.com
Sehen Sie sich das Profil von Yaping Shou auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. Yaping Shou hat 4 Jobs im Profil angegeben. Sehen Sie sich auf ...
Yaping Shou | LinkedIn
www.linkedin.com
View Yaping Shou's professional profile on LinkedIn. LinkedIn is the world's largest business network, helping professionals like Yaping Shou discover inside ...
AT T - Marker für krebs und biosynthetisches bindeprotein dafür...
patents.google.com
· Yaping Shou: Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity WO A2 (en) : : Genentech, Inc. Antibody drug conjugates and methods EP A2 (de) : : Genentech, Inc. Verfahren zur behandlung von multipler sklerose
CA A1 - Method for making humanized antibodies ...
patents.google.com
Yaping Shou: Methods for detecting lp-pla2 activity and inhibition of lp-pla2 activity WO A2 (en) * : : Genentech, Inc. Treatment of polychondritis and mononeuritis multiplex with anti-cd20 antibodies BRPI B8 (en) : : Genentech Inc
WO A3 - METHODS FOR DETECTING Lp-PLA2 ACTIVITY AND...
patents.google.com
This invention relates to methods for determining the activity of Lp-PLA2 in at least one sample from an animal. The invention also relates to methods...
US B2 - High throughput assay of Lp-PLA2 activity
patents.google.com
This invention relates to a method for determining the activity of Lp-PLA2 in a plurality of samples from animals. The invention also relates to a kit...
Yaping Shou in Acton, MA - Listing Details - Yellow Pages Goes Green...
www.yellowpagesdirectory.com
Yaping Shou is located in Acton MA according to public information records. First Name, Phone Number, Name Origin and Meaning for the person identified in our...
Searching for in ALL - Instant Checkmate
206-225-85-34.dedicated.abac.net
Instant access to millions of criminal, court documents and more with Instant Checkmate. Find out the truth.
Yaping Shou in Cary, NC - Listing Details - Yellow Pages Goes Green ®...
www.yellowpagesdirectory.com
Yaping Shou is located in Cary NC according to public information records. First Name, Phone Number, Name Origin and Meaning for the person identified in our...
Yaping Shou in Morrisville, NC - Listing Details - Yellow Pages Goes...
www.yellowpagesdirectory.com
Yaping Shou is located in Morrisville NC according to public information records. First Name, Phone Number, Name Origin and Meaning for the person identified...
A phase I, multicenter, open-label, first-in-human, dose-escalation...
scholars.uthscsa.edu
Jordi Rodon ; Hussein A. Tawbi ; Anne L. Thomas ; Ronald G. Stoller ; Christian P. Turtschi ; Jose Baselga ; John Sarantopoulos; Devalingam Mahalingam; Yaping Shou ...
A First-in-Human, Phase I, Dose-Escalation Study of TAK ...
aacrjournals.org
· Dejan Juric, Johann S de Bono, Patricia M. LoRusso, John Nemunaitis, Elisabeth I Heath, Eunice L. Kwak, Teresa Macarulla Mercadé, Elena Geuna, Maria Jose de Miguel-Luken, Chirag Patel, Keisuke Kuida, Serap Sankoh, Eric H Westin, Fabian Zohren, Yaping Shou, Josep Tabernero; A First-in-Human, Phase I, Dose-Escalation Study of TAK-117, a Selective …
Impact of Baseline BCR-ABL Mutations on Response to Nilotinib in...
hwmaint.jco.ascopubs.org
Manuscript writing: Timothy Hughes, Susan Branford, Giovanni Martinelli, Yaping Shou, Neil Gallagher, Jerald Radich, Andreas Hochhaus. Final approval of manuscript: ...
Investigational CD47-Blocker TTI-622 Shows Single-Agent ...
ashpublications.org
· Krish Patel, Radhakrishnan Ramchandren, Michael Maris, Alexander M. Lesokhin, Gottfried R. von Keudell, Bruce D. Cheson, Jeff Zonder, Erlene K. Seymour, Tina Catalano, Gloria H. Y. Lin, Bob Uger, Penka S. Petrova, Kathleen Roberge, Yaping Shou, Swami P. Iyer; Investigational CD47-Blocker TTI-622 Shows Single-Agent Activity in Patients with Advanced Relapsed or …
(PDF) Nilotinib (formerly AMN107), a highly selective BCR-ABL...
www.academia.edu
Cervantes,11 Ariful Haque,12 Yaping Shou,12 Debra J. Resta,12 Aaron
Weitzman ...
Mutations of c-myc May Play Role in Myeloma Progression
www.cancernetwork.com
· We have screened genomic DNA from 20 multiple myeloma cell lines in our lab for mutations in c-myc exons, and in six of these, we have found two genetically distinct c-myc alleles a normal wildtype allele plus a polymorphic allele containing a silent mutation, said Yaping Shou, MD, PhD, of the National Cancer Institute, Medicine Branch.
Xu, Zangwei & Yaping Shou Great Ridge Ct, Morrisville, Nc
www.arivify.com
Property record for 308 GREAT RIDGE CT, MORRISVILLE, NC which is owned by Xu, Zangwei & Yaping Shou.
Nilotinib is associated with a reduced incidence of BCR ...
ashpublications.org
· Andreas Hochhaus, Giuseppe Saglio, Richard A. Larson, Dong-Wook Kim, Gabriel Etienne, Gianantonio Rosti, Carmino De Souza, Mineo Kurokawa, Matt E. Kalaycio, Albert Hoenekopp, Xiaolin Fan, Yaping Shou, Hagop M. Kantarjian, Timothy P. Hughes; Nilotinib is associated with a reduced incidence of BCR-ABL mutations vs imatinib in patients with newly …
ASH pick of abstracts | CML Support
cmlsupport.org.uk
Novel CML Drug Active After Failures of Imatinib, Dasatinib, and Nilotinib Elsevier Global Medical News Dec 6, JS MacNeil
Related search requests for Yaping Shou
| Giovanni Martinelli Andreas Hochhaus Simona Soverini | Giuseppe Saglio Jordi Rodon |
People Forename "Yaping" (70) Name "Shou" (147) |
sorted by relevance / date